Yunipro PAO
MOEX:UPRO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.56
2.306
|
Price Target |
|
We'll email you a reminder when the closing price reaches RUB.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Yunipro PAO
Current Assets | 87B |
Cash & Short-Term Investments | 72.6B |
Receivables | 8.8B |
Other Current Assets | 5.5B |
Non-Current Assets | 101.1B |
Long-Term Investments | 740.8m |
PP&E | 96.1B |
Intangibles | 812.8m |
Other Non-Current Assets | 3.5B |
Current Liabilities | 9.6B |
Accounts Payable | 3.3B |
Accrued Liabilities | 4.2B |
Other Current Liabilities | 2B |
Non-Current Liabilities | 4.4B |
Long-Term Debt | 631.4m |
Other Non-Current Liabilities | 3.7B |
Balance Sheet
Yunipro PAO
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
13 101
|
9 363
|
1 725
|
3 058
|
4 788
|
3 094
|
192
|
30
|
27 077
|
50 137
|
|
Cash Equivalents |
13 101
|
9 363
|
1 725
|
3 058
|
4 788
|
3 094
|
192
|
30
|
27 077
|
50 137
|
|
Short-Term Investments |
919
|
143
|
780
|
3 699
|
964
|
1 144
|
764
|
781
|
1 499
|
1 969
|
|
Total Receivables |
5 562
|
6 762
|
5 107
|
9 109
|
6 458
|
6 797
|
7 168
|
7 686
|
7 593
|
9 503
|
|
Accounts Receivables |
4 491
|
5 069
|
4 788
|
4 993
|
5 590
|
5 441
|
6 148
|
6 179
|
7 270
|
8 684
|
|
Other Receivables |
1 071
|
1 693
|
319
|
4 116
|
868
|
1 356
|
1 021
|
1 508
|
323
|
819
|
|
Inventory |
2 150
|
2 167
|
2 305
|
2 507
|
3 424
|
3 334
|
3 415
|
4 217
|
4 632
|
4 700
|
|
Other Current Assets |
471
|
375
|
138
|
175
|
274
|
106
|
104
|
455
|
455
|
6
|
|
Total Current Assets |
22 203
|
18 810
|
10 054
|
18 548
|
15 907
|
14 474
|
11 643
|
13 170
|
41 256
|
66 315
|
|
PP&E Net |
102 997
|
105 903
|
96 701
|
107 182
|
113 932
|
121 159
|
122 271
|
112 286
|
102 010
|
95 439
|
|
PP&E Gross |
102 997
|
105 903
|
96 701
|
107 182
|
113 932
|
121 159
|
122 271
|
112 286
|
102 010
|
95 439
|
|
Accumulated Depreciation |
7 558
|
8 506
|
10 162
|
10 798
|
11 863
|
13 035
|
13 955
|
15 985
|
18 254
|
21 198
|
|
Intangible Assets |
1 165
|
324
|
334
|
338
|
349
|
308
|
353
|
605
|
700
|
715
|
|
Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
56
|
881
|
1 240
|
56
|
132
|
252
|
358
|
552
|
646
|
680
|
|
Other Long-Term Assets |
780
|
847
|
809
|
853
|
705
|
396
|
645
|
836
|
1 754
|
3 102
|
|
Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
127 699
N/A
|
126 765
-1%
|
109 139
-14%
|
126 977
+16%
|
131 025
+3%
|
136 589
+4%
|
135 271
-1%
|
127 448
-6%
|
146 367
+15%
|
166 252
+14%
|
|
Liabilities | |||||||||||
Accounts Payable |
3 990
|
4 581
|
3 750
|
3 725
|
4 215
|
4 280
|
4 862
|
5 126
|
5 343
|
3 620
|
|
Accrued Liabilities |
2 060
|
3 327
|
1 919
|
2 289
|
3 002
|
2 587
|
2 795
|
3 308
|
4 528
|
4 226
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
2 308
|
222
|
237
|
237
|
237
|
185
|
185
|
185
|
|
Other Current Liabilities |
1 024
|
997
|
601
|
361
|
367
|
2 699
|
707
|
3 671
|
189
|
907
|
|
Total Current Liabilities |
7 074
|
8 905
|
8 578
|
6 597
|
7 821
|
9 803
|
8 602
|
12 290
|
10 246
|
8 938
|
|
Long-Term Debt |
0
|
0
|
0
|
747
|
516
|
403
|
921
|
697
|
635
|
606
|
|
Deferred Income Tax |
5 699
|
6 951
|
5 339
|
5 374
|
5 332
|
4 462
|
3 884
|
4 716
|
4 108
|
2 473
|
|
Minority Interest |
0
|
201
|
201
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
932
|
801
|
710
|
724
|
1 123
|
1 275
|
1 321
|
1 093
|
1 667
|
1 739
|
|
Total Liabilities |
14 231
N/A
|
16 858
+18%
|
14 827
-12%
|
13 441
-9%
|
14 791
+10%
|
15 943
+8%
|
14 727
-8%
|
18 795
+28%
|
16 656
-11%
|
13 756
-17%
|
|
Equity | |||||||||||
Common Stock |
25 219
|
25 219
|
25 219
|
25 219
|
25 219
|
25 219
|
25 219
|
25 219
|
25 219
|
25 219
|
|
Retained Earnings |
48 196
|
44 635
|
29 039
|
48 264
|
50 962
|
55 374
|
55 273
|
43 381
|
64 438
|
87 224
|
|
Additional Paid In Capital |
40 052
|
40 052
|
40 052
|
40 052
|
40 052
|
40 052
|
40 052
|
40 052
|
40 052
|
40 052
|
|
Total Equity |
113 468
N/A
|
109 907
-3%
|
94 311
-14%
|
113 536
+20%
|
116 234
+2%
|
120 646
+4%
|
120 544
0%
|
108 653
-10%
|
129 710
+19%
|
152 496
+18%
|
|
Total Liabilities & Equity |
127 699
N/A
|
126 765
-1%
|
109 139
-14%
|
126 977
+16%
|
131 025
+3%
|
136 589
+4%
|
135 271
-1%
|
127 448
-6%
|
146 367
+15%
|
166 252
+14%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
63 049
|
63 049
|
63 049
|
63 049
|
63 049
|
63 049
|
63 049
|
63 049
|
63 049
|
63 049
|